NEW YORK, April 18, 2019 /PRNewswire/ -- Jaci Hermstad a 25 year old cowgirl from Spencer Iowa. Jaci has a rare form of childhood onset ALS called FUS P525L, that is raging in her like a wildfire.
ALS is one of the worst diseases in the world and FUS P525L is one of the most severe, aggressive forms of ALS. Jaci does not need her doctors to tell her how bad it is, because her identical twin sister was stricken with the same disease and she watched her die, at age 17.
Researchers are working on a ground breaking experimental drug called 'ASO' that could save her life. The procedure is being designed especially for her. It is a new procedure that will be considered for 'compassionate use.' But the process is expensive - Jaci is trying to raise the funds to give her a chance to be part of this treatment, so she has set up a GoFundMe Campaign to raise the funds.She wants to have the chance to LIVE.
WHERE THE MONEY IS GOING All funds raised on Jaci's campaign will be transferred directly to the manufacturing of the Experimental drug called 'ASO' that could save her life.
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme").
For this purpose, Sobi has prepared a base prospectus, which...
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...
Today, RaySearch Laboratories AB (publ) publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.
This information is information that RaySearch Larboratiories AB...
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM.
The company aims to webcast the...
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website.
"Implantica had a very...
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...
